Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics Inc (NQ: IOVA )

8.000 -0.240 (-2.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,050,552
Open 8.250
Bid (Size) 7.960 (4)
Ask (Size) 8.030 (8)
Prev. Close 8.240
Today's Range 7.930 - 8.300
52wk Range 5.280 - 13.44
Shares Outstanding 224,448,554
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics. 
Via Talk Markets
Why Shares of Iovance Biotherapeutics Jumped Tuesday
The company received approval for a biologics license application for an advanced melanoma therapy. 
Via The Motley Fool

Performance

YTD
+30.93%
+30.93%
1 Month
+12.99%
+12.99%
3 Month
+15.27%
+15.27%
6 Month
+10.27%
+10.27%
1 Year
-3.85%
-3.85%

More News

Read More
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Analyst Expectations for Iovance Biotherapeutics's Future
Via Benzinga
What's Going On With Iovance Biotherapeutics Stock?
Via Benzinga
Where Iovance Biotherapeutics Stands With Analysts
Via Benzinga
Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application
Via MarketBeat
Topics Death
Exposures Death Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Analyst Ratings for Iovance Biotherapeutics
Via Benzinga
Recap: Iovance Biotherapeutics Q1 Earnings
Via Benzinga
Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon
Via The Motley Fool
Analyst Expectations for Iovance Biotherapeutics's Future
Via Benzinga
Gaotu Techedu, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Ulta Beauty, Tilray Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Iovance Biotherapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Iovance Biotherapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, May 9, 2023
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Why Shares of Iovance Biotherapeutics Jumped Monday
Via The Motley Fool
Iovance Biotherapeutics to Present at Upcoming Conferences
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Why Shares of Iovance Biotherapeutics Jumped Monday
Via The Motley Fool
Why Iovance Biotherapeutics Shares Are Trading Higher Today
Via Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.